{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:31:49Z","timestamp":1786480309415,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2022,11,24]]},"abstract":"\n Key Points<\/jats:title>\n \n \n \n \n Missense variants in\n COL4A<\/jats:italic>\n genes can cause mild forms of Alport syndrome.\n <\/jats:p>\n <\/jats:list-item>\n \n Combining pathology and genetics with basic science can successfully determine the pathogenicity of variants of uncertain significance.<\/jats:p>\n <\/jats:list-item>\n \n Low-throughput, mechanistic approaches, applied broadly, may provide a critical next step for precision and personalized medicine.<\/jats:p>\n <\/jats:list-item>\n <\/jats:list>\n <\/jats:p>\n <\/jats:sec>\n \n Background<\/jats:title>\n \n Missense variants in\n COL4A<\/jats:italic>\n genes are often found in patients with an Alport syndrome\u2013like presentation, but their pathogenicity is not always clear. We encountered a woman with microscopic hematuria and proteinuria at 33 years of age with a diagnosis of thin basement membrane disease who was approaching end stage kidney disease at 59 years of age. We hypothesized that this patient\u2019s kidney disease was within the spectrum of Alport syndrome.\n <\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n We used histologic, genetic, and biochemical approaches to investigate the mechanisms of kidney disease. By immunofluorescence, we investigated collagen IV chain composition of the glomerular basement membrane (GBM). We employed targeted sequencing to search for pathogenic variants in\n COL4A<\/jats:italic>\n and other relevant genes. We utilized N- and C-terminal split NanoLuciferase assays to determine the effect of a novel\n COL4A4<\/jats:italic>\n variant of uncertain significance (VUS) on collagen IV heterotrimer formation\n in vitro<\/jats:italic>\n . We transfected COL4A4 expression constructs with split NanoLuciferase fragment-fused COL4A3 and COL4A5 constructs into human embryonic kidney 293T cells. To assay for\n \u03b1<\/jats:italic>\n 3\n \u03b1<\/jats:italic>\n 4\n \u03b1<\/jats:italic>\n 5(IV) heterotrimer formation and secretion, we measured luminescence in cell lysates and culture supernatants from transfected cells.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Immunostaining suggested that the collagen\n \u03b1<\/jats:italic>\n 3\n \u03b1<\/jats:italic>\n 4\n \u03b1<\/jats:italic>\n 5(IV) network was present throughout the patient\u2019s GBMs. DNA sequencing revealed a novel homozygous VUS:\n COL4A4<\/jats:italic>\n c.1180G>A (p. Gly394Ser). In the C-terminal split luciferase-based\n \u03b1<\/jats:italic>\n 3\n \u03b1<\/jats:italic>\n 4\n \u03b1<\/jats:italic>\n 5(IV) heterotrimer formation assays, luminescence levels for G394S were comparable to WT, but in the N-terminal tag assays, the extracellular luminescence levels for G394S were decreased by approximately 50% compared with WT.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n \n Our cell-based assay provides a platform to test\n COL4<\/jats:italic>\n VUS and shows that G394S impairs assembly of the\n \u03b1<\/jats:italic>\n 3\n \u03b1<\/jats:italic>\n 4\n \u03b1<\/jats:italic>\n 5(IV) N-terminus and subsequent trimer secretion. These data suggest that the COL4A4-G394S variant is pathogenic and causes an atypical mild form of autosomal recessive Alport syndrome.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.34067\/kid.0005472022","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T18:25:13Z","timestamp":1666808713000},"page":"1899-1908","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["A COL4A4-G394S Variant and Impaired Collagen IV Trimerization in a Patient with Mild Alport Syndrome"],"prefix":"10.34067","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0830-3535","authenticated-orcid":false,"given":"Jennefer","family":"Kohler","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0160-3271","authenticated-orcid":false,"given":"Kohei","family":"Omachi","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7147-9026","authenticated-orcid":false,"given":"Vivek","family":"Charu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1510-8714","authenticated-orcid":false,"given":"Jeffrey H.","family":"Miner","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5420-9657","authenticated-orcid":false,"given":"Vivek","family":"Bhalla","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Stanford School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,11,24]]},"reference":[{"key":"B1-20250825","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0002-9343(81)90571-4","article-title":"Alport\u2019s syndrome. A report of 58 cases and a review of the literature","volume":"70","author":"Gubler","year":"1981","journal-title":"Am J Med"},{"key":"B2-20250825","first-page":"S20","article-title":"Alport\u2019s syndrome: Experience at H\u00f4pital Necker","volume":"11","author":"Habib","year":"1982","journal-title":"Kidney Int Suppl"},{"key":"B3-20250825","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00467-018-4121-1","article-title":"Alport syndrome: Deducing the mode of inheritance from the presence of haematuria in family members","volume":"35","author":"Savige","year":"2020","journal-title":"Pediatr Nephrol"},{"key":"B4-20250825","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/s41431-021-00858-1","article-title":"Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: Refining the ACMG criteria","volume":"29","author":"Savige","year":"2021","journal-title":"Eur J Hum Genet"},{"key":"B5-20250825","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1681\/ASN.2020071065","article-title":"Prevalence estimates of predicted pathogenic COL4A3-COL4A5 variants in a population sequencing database and their implications for Alport syndrome","volume":"32","author":"Gibson","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"B6-20250825","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2215\/CJN.19171220","article-title":"Genetic basis of type IV collagen disorders of the kidney","volume":"16","author":"Quinlan","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"B7-20250825","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.matbio.2018.04.008","article-title":"Alport syndrome and Pierson syndrome: Diseases of the glomerular basement membrane","volume":"71-72","author":"Funk","year":"2018","journal-title":"Matrix Biol"},{"key":"B8-20250825","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2215\/CJN.04230321","article-title":"Guidelines for genetic testing and management of Alport syndrome","volume":"17","author":"Savige","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"B9-20250825","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/jmedgenet-2014-102822","article-title":"Evidence of digenic inheritance in Alport syndrome","volume":"52","author":"Mencarelli","year":"2015","journal-title":"J Med Genet"},{"key":"B10-20250825","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2147\/JMDH.S284784","article-title":"Multidisciplinary management of Alport syndrome: Current perspectives","volume":"14","author":"Kashtan","year":"2021","journal-title":"J Multidiscip Healthc"},{"key":"B11-20250825","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.kint.2017.12.018","article-title":"Alport syndrome: A unified classification of genetic disorders of collagen IV \u03b1345: A position paper of the Alport Syndrome Classification Working Group","volume":"93","author":"Kashtan","year":"2018","journal-title":"Kidney Int"},{"key":"B12-20250825","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/ki.2014.326","article-title":"Pathology vs. molecular genetics: (Re)defining the spectrum of Alport syndrome","volume":"86","author":"Miner","year":"2014","journal-title":"Kidney Int"},{"key":"B13-20250825","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1681\/ASN.2013080912","article-title":"Improving mutation screening in familial hematuric nephropathies through next generation sequencing","volume":"25","author":"Morini\u00e8re","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B14-20250825","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.xkme.2020.12.007","article-title":"Type IV collagen variants in CKD: Performance of computational predictions for identifying pathogenic variants","volume":"3","author":"Shulman","year":"2021","journal-title":"Kidney Med"},{"key":"B15-20250825","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1083\/jcb.127.3.879","article-title":"Collagen IV alpha 3, alpha 4, and alpha 5 chains in rodent basal laminae: Sequence, distribution, association with laminins, and developmental switches","volume":"127","author":"Miner","year":"1994","journal-title":"J Cell Biol"},{"key":"B16-20250825","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.chembiol.2018.02.003","article-title":"A split-luciferase-based trimer formation assay as a high-throughput screening platform for therapeutics in Alport syndrome","volume":"25","author":"Omachi","year":"2018","journal-title":"Cell Chem Biol"},{"key":"B17-20250825","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"B18-20250825","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1021\/acschembio.5b00753","article-title":"NanoLuc complementation reporter optimized for accurate measurement of protein interactions in cells","volume":"11","author":"Dixon","year":"2016","journal-title":"ACS Chem Biol"},{"key":"B19-20250825","doi-asserted-by":"crossref","first-page":"103891","DOI":"10.1016\/j.isci.2022.103891","article-title":"NanoLuc reporters identify COL4A5 nonsense mutations susceptible to drug-induced stop codon readthrough","volume":"25","author":"Omachi","year":"2022","journal-title":"iScience"},{"key":"B20-20250825","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ekir.2020.01.008","article-title":"Trimerization and genotype-phenotype correlation of COL4A5 mutants in Alport syndrome","volume":"5","author":"Kamura","year":"2020","journal-title":"Kidney Int Rep"},{"key":"B21-20250825","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1086\/302106","article-title":"Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome","volume":"63","author":"Boye","year":"1998","journal-title":"Am J Hum Genet"},{"key":"B22-20250825","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1046\/j.1523-1755.2003.00780.x","article-title":"Mutations in the COL4A4 gene in thin basement membrane disease","volume":"63","author":"Buzza","year":"2003","journal-title":"Kidney Int"},{"key":"B23-20250825","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00007890-200301150-00012","article-title":"Recurrent and de novo diabetic nephropathy in renal allografts","volume":"75","author":"Bhalla","year":"2003","journal-title":"Transplantation"},{"key":"B24-20250825","doi-asserted-by":"crossref","first-page":"900","DOI":"10.34067\/KID.0004162021","article-title":"The KIDNEYCODE program: Diagnostic yield and clinical features of individuals with chronic kidney disease","volume":"3","author":"Lieberman","year":"2022","journal-title":"Kidney360"},{"key":"B25-20250825","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000522226","article-title":"Genetic etiologies for chronic kidney disease revealed through next-generation renal gene panel","volume":"53","author":"Bleyer","year":"2022","journal-title":"Am J Nephrol"},{"key":"B26-20250825","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/ki.2013.479","article-title":"Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV \u03b15 chain","volume":"85","author":"Hashimura","year":"2014","journal-title":"Kidney Int"},{"key":"B27-20250825","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00467-019-04241-7","article-title":"The importance of clinician, patient and researcher collaborations in Alport syndrome","volume":"35","author":"Rheault","year":"2020","journal-title":"Pediatr Nephrol"}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0005472022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:02:23Z","timestamp":1786478543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0005472022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,24]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0005472022","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,24]]},"assertion":[{"value":"2022-08-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}